Avricore Health (AVCRF) Operating Expenses (2009 - 2026)

Avricore Health (AVCRF) has reported Operating Expenses for 18 consecutive years, with $69894.6 the latest figure, recorded in Q2 2026.

• In Q2 2026, Operating Expenses fell 31.51% year-over-year to $69894.6; the TTM figure through Jun 2026 stood at $254900.4 (down 57.04% YoY), while the FY2025 annual figure was $367492.9, down 71.27% from the prior year.
• Operating Expenses improved to $69894.6 in Q2 2026 per AVCRF's latest filing, from $28922.5 in the prior quarter.
• Across five years, Operating Expenses topped out at $407485.4 in Q3 2023 and bottomed at $28922.5 in Q1 2026.
• Historically, Operating Expenses has averaged $182291.3 across 5 years, with a median of $138568.9 in 2024.
• Annual changes were most pronounced in 2022 — Operating Expenses soared 629.91% — and 2024, when it tumbled 83.53%.
• Avricore Health's Operating Expenses stood at $300244.8 in 2022, then grew by 5.88% to $317901.8 in 2023, then sank by 83.53% to $52366.5 in 2024, then dropped by 11.21% to $46496.6 in 2025, then jumped by 50.32% to $69894.6 in 2026.
• Business Quant data shows AVCRF's Operating Expenses at $69894.6 in Q2 2026, $28922.5 in Q1 2026, and $46496.6 in Q4 2025.